Fritextsökning
Innehållstyper
-
New CEO to Swedish Tillotts Pharma
The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
App hittar ojämn hjärtrytm
Det dyker upp allt fler mobilappar med medicinsk koppling. En är Instant heart rate som gör det enkelt att upptäcka hjärtrytmstörningar.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Presenterar data från två kliniska studier
Sobi och partnern Biogen visar upp nya resultat på kongress i Kanada.
-
Annika Garnås, LAB
Why are you going to Scanlab+Biotech Forum?
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Framtidens entreprenörer tror på ny teknik som väg till förändringar
Prevention istället för symtomatisk behandling och fler virtuella bolag är några av de spådomar som kom fram under en paneldiskussion på Sweden Bios tioårsjubil...
-
Biovitrum får orphan drug-status i EU
Färre behandlingstillfällen för blödarsjuka är i sikte med Swedish Orphan Biovitrums läkemedelskandidat. Nu kan läkemedlet nå den europeiska marknaden fortare.
-
Swetox får 30 miljoner
Ska forska på hormonstörande ämnen.
-
Han blir kommersiell chef på Sobi
Hemofililedare tar ansvar över kommande kommersialisering.
-
Pengar till smarta minifabriker
För att främja digitaliserad svensk industri finansierar Vinnova åtta projekt som ska bana väg för framtida digital industri. Smarta minifabriker för läkemedels...
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
-
Metabolic pro heads prefect post
The dean of the Department of Biomedicine at the Sahlgrenska Academy has appointed a new assistant prefect.
-
Multilabel plate readers with luminescence capability
The Enspire Multilabel Plate Reader platform from Perkin Elmer now features sensitive luminescence detection. The new detection capability is primarily aimed at...
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Blackmer lanserar ny serie oljefria gaskolvkompressorer | AxFlow AB
Blackmer presenterar en ny serie av trippeltätade, oljefria gaskolvkompressorer.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
BREAKING